$CLRI
Cleartronic, Inc. Stock $clri

$clri Overview Financials Valuation SEC Filings Company Website

2014 Q3 Form 10-Q Financial Statement

#000109181814000223 Filed on August 14, 2014

Income Statement

Concept	2014 Q3	2014 Q2	2013 Q2
Revenue	$50.00K	$38.74K	$90.54K
YoY Change	-58.33%	-57.21%	69.52%
Cost Of Revenue	$20.00K	$21.64K	$65.97K
YoY Change	-71.43%	-67.2%	176.96%
Gross Profit	$30.00K	$17.11K	$24.57K
YoY Change	-40.0%	-30.37%	-16.97%
Gross Profit Margin	60.0%	44.15%	27.13%
Selling, General & Admin	$80.00K	$56.62K	$319.5K
YoY Change	-74.19%	-82.28%	64.34%
% of Gross Profit	266.67%	330.99%	1300.52%
Research & Development	$0.00	$3.000K
YoY Change	-100.0%
% of Gross Profit	0.0%	17.54%
Depreciation & Amortization	$0.00	$0.00	$0.00
YoY Change			-100.0%
% of Gross Profit	0.0%	0.0%	0.0%
Operating Expenses	$80.00K	$59.62K	$319.5K
YoY Change	-75.0%	-81.34%	44.03%
Operating Profit	-$50.00K	-$42.51K	-$294.9K
YoY Change	-81.48%	-85.59%	53.42%
Interest Expense	-$20.00K	$15.22K	-$30.00K
YoY Change	0.0%	-150.74%	-50.0%
% of Operating Profit
Other Income/Expense, Net		-$15.22K	-$20.11K
YoY Change		-24.32%	-68.62%
Pretax Income	-$60.00K	-$60.00K	-$320.0K
YoY Change	-79.31%	-81.25%	28.0%
Income Tax	$0.00	$0.00	$0.00
% Of Pretax Income
Net Earnings	-$60.00K	-$57.73K	-$320.5K
YoY Change	-79.31%	-81.99%	29.44%
Net Earnings / Revenue	-120.0%	-149.02%	-353.99%
Basic Earnings Per Share
Diluted Earnings Per Share	-$26.51	-$28.25	-$155.60
COMMON SHARES
Basic Shares Outstanding	2.125B shares	2.124B shares
Diluted Shares Outstanding

Balance Sheet

Concept	2014 Q3	2014 Q2	2013 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$0.00	$10.00K	$10.00K
YoY Change	-100.0%	0.0%	0.0%
Cash & Equivalents	$2.505K	$8.858K	$13.07K
Short-Term Investments
Other Short-Term Assets	$10.00K	$10.00K	$270.0K
YoY Change	-85.71%	-96.3%	440.0%
Inventory	$16.09K	$21.92K	$26.72K
Prepaid Expenses
Receivables		$803.00
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$27.26K	$40.24K	$308.5K
YoY Change	-78.25%	-86.96%	208.45%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets	$0.00	$0.00	$0.00
YoY Change			-100.0%
TOTAL ASSETS
Total Short-Term Assets	$27.26K	$40.24K	$308.5K
Total Long-Term Assets	$0.00	$0.00	$0.00
Total Assets	$27.26K	$40.24K	$308.5K
YoY Change	-78.25%	-86.96%	180.41%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$387.6K	$370.6K	$415.4K
YoY Change	-12.46%	-10.79%	-24.48%
Accrued Expenses	$286.0K	$274.2K	$207.2K
YoY Change	20.82%	32.35%	-20.31%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change			-100.0%
Long-Term Debt Due	$180.0K	$180.0K	$330.0K
YoY Change	-45.45%	-45.45%	13.79%
Total Short-Term Liabilities	$896.0K	$845.0K	$991.2K
YoY Change	-15.08%	-14.75%	-19.41%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$0.00	$0.00	$20.00K
YoY Change	-100.0%	-100.0%	-33.33%
Total Long-Term Liabilities	$2.825K	$0.00	$20.00K
YoY Change	-73.61%	-100.0%	-33.33%
TOTAL LIABILITIES
Total Short-Term Liabilities	$896.0K	$845.0K	$991.2K
Total Long-Term Liabilities	$2.825K	$0.00	$20.00K
Total Liabilities	$898.8K	$849.1K	$1.007M
YoY Change	-15.67%	-15.71%	-20.06%
SHAREHOLDERS EQUITY
Retained Earnings	-$12.10M	-$12.04M	-$11.51M
YoY Change	2.54%	4.6%
Common Stock	$21.25K	$21.25K	$20.57K
YoY Change	3.25%	3.3%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$871.6K	-$808.8K	-$698.8K
YoY Change
Total Liabilities & Shareholders Equity	$27.26K	$40.24K	$308.5K
YoY Change	-78.22%	-86.96%	180.41%

Cashflow Statement

Concept	2014 Q3	2014 Q2	2013 Q2
OPERATING ACTIVITIES
Net Income	-$60.00K	-$57.73K	-$320.5K
YoY Change	-79.31%	-81.99%	29.44%
Depreciation, Depletion And Amortization	$0.00	$0.00	$0.00
YoY Change			-100.0%
Cash From Operating Activities	-$10.00K	-$50.00K	-$30.00K
YoY Change		66.67%	-50.0%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	0.000	60.00K	20.00K
YoY Change	-100.0%	200.0%
NET CHANGE
Cash From Operating Activities	-10.00K	-50.00K	-30.00K
Cash From Investing Activities
Cash From Financing Activities	0.000	60.00K	20.00K
Net Change In Cash	-10.00K	10.00K	-10.00K
YoY Change	-200.0%	-200.0%	-83.33%
FREE CASH FLOW
Cash From Operating Activities	-$10.00K	-$50.00K	-$30.00K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	clri	Convertible Notes Payable And Derivative Liability Converted Into Stock ConvertibleNotesPayableAndDerivativeLiabilityConvertedIntoStock	7700	USD
	clri	Debt Conversion Converted Accounts Payable Amount DebtConversionConvertedAccountsPayableAmount	623215	USD
	clri	Debt Conversion Converted Derivative Liabilities Amount DebtConversionConvertedDerivativeLiabilitiesAmount	27363	USD
CY2014Q2	clri	Debt Instrument Convertible Conversion Price Percentage Of Variable Conversion Rate DebtInstrumentConvertibleConversionPricePercentageOfVariableConversionRate	0.58	pure
CY2014Q2	clri	Debt Instrument Convertible Default Immediate Payment Percentage DebtInstrumentConvertibleDefaultImmediatePaymentPercentage	1.5	pure
CY2013Q2	clri	Debt Instrument Convertible Default Immediate Payment Percentage DebtInstrumentConvertibleDefaultImmediatePaymentPercentage	1.5	pure
CY2014Q2	clri	Debt Instrument Convertible Number Of Closing Prices Averaged In Variable Conversion Rate DebtInstrumentConvertibleNumberOfClosingPricesAveragedInVariableConversionRate	3	pure
	clri	Debt Instrument Convertible Number Of Prior Trading Days Closing Prices Considered In Variable Conversion Rate DebtInstrumentConvertibleNumberOfPriorTradingDaysClosingPricesConsideredInVariableConversionRate	P10D
CY2014Q2	clri	Debt Instrument Convertible Number Of Prior Trading Days Closing Prices Considered In Variable Conversion Rate DebtInstrumentConvertibleNumberOfPriorTradingDaysClosingPricesConsideredInVariableConversionRate	P10D
	clri	Debt Instrument Convertible Period After Which Debt Is Convertible DebtInstrumentConvertiblePeriodAfterWhichDebtIsConvertible	P180D
CY2014Q2	clri	Debt Instrument Convertible Period After Which Debt Is Convertible DebtInstrumentConvertiblePeriodAfterWhichDebtIsConvertible	P180D
	clri	Debt Instrument Convertible Prepayment Options Third Prepayment Period Days Upper Limit DebtInstrumentConvertiblePrepaymentOptionsThirdPrepaymentPeriodDaysUpperLimit	P180D
CY2014Q2	clri	Debt Instrument Convertible Prepayment Options Third Prepayment Period Days Upper Limit DebtInstrumentConvertiblePrepaymentOptionsThirdPrepaymentPeriodDaysUpperLimit	P180D
	clri	Gain Loss On Exchange Of Stock And Stock Equivalents GainLossOnExchangeOfStockAndStockEquivalents		USD
	clri	Gain Loss On Exchange Of Stock And Stock Equivalents GainLossOnExchangeOfStockAndStockEquivalents	1273732	USD
CY2014Q2	clri	Gain Loss On Exchange Of Stock And Stock Equivalents GainLossOnExchangeOfStockAndStockEquivalents		USD
CY2013Q2	clri	Gain Loss On Exchange Of Stock And Stock Equivalents GainLossOnExchangeOfStockAndStockEquivalents	5446	USD
	clri	Gain Loss On Share Exchange GainLossOnShareExchange		USD
	clri	Gain Loss On Share Exchange GainLossOnShareExchange	-1273732	USD
	us-gaap	Adjustments To Additional Paid In Capital Equity Component Of Convertible Debt AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt		USD
CY2014Q2	clri	Receivables Factoring Discount Rate Higher Range ReceivablesFactoringDiscountRateHigherRange	0.0625	pure
CY2014Q2	clri	Receivables Factoring Discount Rate Lower Range ReceivablesFactoringDiscountRateLowerRange	0.0225	pure
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--09-30
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2014
	dei	Document Period End Date DocumentPeriodEndDate	2014-06-30
	dei	Document Type DocumentType	10-Q
	dei	Entity Central Index Key EntityCentralIndexKey	0001362516
CY2014Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	2124900908	shares
	dei	Entity Filer Category EntityFilerCategory	Smaller Reporting Company
	dei	Entity Registrant Name EntityRegistrantName	Cleartronic, Inc.
CY2014Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	370560	USD
CY2013Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	442752	USD
CY2014Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	803	USD
CY2013Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	22404	USD
CY2014Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	274224	USD
CY2013Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	236680	USD
CY2014Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	11208385	USD
CY2013Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	10839980	USD
	us-gaap	Adjustments To Additional Paid In Capital Equity Component Of Convertible Debt AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt	65000	USD
	us-gaap	Advertising Expense AdvertisingExpense	6374	USD
	us-gaap	Advertising Expense AdvertisingExpense	7449	USD
CY2014Q2	us-gaap	Advertising Expense AdvertisingExpense	2291	USD
CY2013Q2	us-gaap	Advertising Expense AdvertisingExpense	2720	USD
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium		USD
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	51618	USD
	us-gaap	Amortization Of Deferred Loan Origination Fees Net AmortizationOfDeferredLoanOriginationFeesNet		USD
	us-gaap	Amortization Of Deferred Loan Origination Fees Net AmortizationOfDeferredLoanOriginationFeesNet	-1331	USD
CY2014Q2	us-gaap	Assets Assets	40235	USD
CY2013Q3	us-gaap	Assets Assets	125130	USD
CY2014Q2	us-gaap	Assets Current AssetsCurrent	40235	USD
CY2013Q3	us-gaap	Assets Current AssetsCurrent	125130	USD
CY2013Q3	us-gaap	Customer Deposits Current CustomerDepositsCurrent	8428	USD
	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1	143703	USD
CY2013Q3	us-gaap	Common Stock Value CommonStockValue	20581	USD
	us-gaap	Concentration Risk Credit Risk Uninsured Deposits ConcentrationRiskCreditRiskUninsuredDeposits	<!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <p style="font-family: Verdana; FONT-FAMILY: Verdana; MARGIN: 0pt; text-align: justify; TEXT-INDENT: 63.7pt"> <strong>CONCENTRATION OF CREDIT RISK</strong></p> <p style="FONT-FAMILY: Verdana; MARGIN: 0pt; text-align: justify; TEXT-INDENT: 63.7pt">  </p> <p style="font-family: Arial; FONT-FAMILY: Arial; FONT-SIZE: 11pt; LINE-HEIGHT: 13pt; MARGIN: 0pt; PADDING-LEFT: 63.35pt; text-align: justify"> The Company currently maintains cash balances at one FDIC-insured banking institution. Deposits held in noninterest-bearing transaction accounts are insured up to a maximum of $250,000 at all FDIC-insured institutions.</p> <!--EndFragment--></div> </div>
CY2014Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	8858	USD
CY2013Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	11188	USD
CY2013Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	13074	USD
CY2012Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	38420	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-2330	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-25346	USD
CY2014Q2	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	250000	USD
CY2014Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2013Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2014Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	5000000000	shares
CY2013Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	5000000000	shares
CY2014Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	2124900908	shares
CY2013Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	2058069648	shares
CY2014Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	2124900908	shares
CY2013Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	2058069648	shares
CY2014Q2	us-gaap	Common Stock Value CommonStockValue	21249	USD
	us-gaap	Cost Of Revenue CostOfRevenue	74910	USD
	us-gaap	Cost Of Revenue CostOfRevenue	180482	USD
CY2014Q2	us-gaap	Cost Of Revenue CostOfRevenue	21637	USD
CY2013Q2	us-gaap	Cost Of Revenue CostOfRevenue	65970	USD
CY2014Q2	us-gaap	Customer Deposits Current CustomerDepositsCurrent		USD
CY2014Q2	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	19491	USD
CY2013Q3	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	36487	USD
CY2014Q2	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	4039	USD
CY2013Q3	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	10704	USD
	us-gaap	Depreciation Depreciation		USD
	us-gaap	Depreciation Depreciation	2342	USD
CY2014Q2	us-gaap	Depreciation Depreciation		USD
CY2013Q2	us-gaap	Depreciation Depreciation		USD
	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet		USD
	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	18055	USD
CY2014Q2	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet		USD
CY2013Q2	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet		USD
	us-gaap	Derivative Gain On Derivative DerivativeGainOnDerivative	123000	USD
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.00012
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.00226
CY2014Q2	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.00003
CY2013Q2	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.00016
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-10583	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-963	USD
	us-gaap	Gain Loss On Repurchase Of Debt Instrument GainLossOnRepurchaseOfDebtInstrument		USD
	us-gaap	Gain Loss On Repurchase Of Debt Instrument GainLossOnRepurchaseOfDebtInstrument	472127	USD
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt		USD
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	472127	USD
CY2014Q2	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt		USD
CY2013Q2	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt		USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	235306	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1767720	USD
CY2014Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	51435	USD
CY2013Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	315702	USD
	us-gaap	Gross Profit GrossProfit	84080	USD
	us-gaap	Gross Profit GrossProfit	126448	USD
CY2014Q2	us-gaap	Gross Profit GrossProfit	17105	USD
CY2013Q2	us-gaap	Gross Profit GrossProfit	24567	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-72122	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-3743	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-21601	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-2468	USD
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	29116	USD
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	72014	USD
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-23661	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-3344	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-60001	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets		USD
	us-gaap	Interest Expense Debt InterestExpenseDebt	17160	USD
	us-gaap	Interest Expense Debt InterestExpenseDebt	22075	USD
CY2014Q2	us-gaap	Interest Expense Debt InterestExpenseDebt	5062	USD
CY2013Q2	us-gaap	Interest Expense Debt InterestExpenseDebt	8604	USD
	us-gaap	Interest Paid InterestPaid	2945	USD
	us-gaap	Interest Paid InterestPaid	32806	USD
CY2014Q2	us-gaap	Inventory Net InventoryNet	21918	USD
CY2013Q3	us-gaap	Inventory Net InventoryNet	22881	USD
CY2014Q2	us-gaap	Inventory Valuation Reserves InventoryValuationReserves		USD
CY2013Q2	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	2492	USD
	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	10000	USD
	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	1560650	USD
CY2014Q2	us-gaap	Liabilities Liabilities	849052	USD
CY2013Q3	us-gaap	Liabilities Liabilities	1065789	USD
CY2014Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	40235	USD
CY2013Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	125130	USD
CY2014Q2	us-gaap	Liabilities Current LiabilitiesCurrent	845013	USD
CY2013Q3	us-gaap	Liabilities Current LiabilitiesCurrent	1055085	USD
	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	209000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	84325	USD
	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-211330	USD
	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-109671	USD
	us-gaap	Net Income Loss NetIncomeLoss	-237228	USD
	us-gaap	Net Income Loss NetIncomeLoss	-2572662	USD
CY2014Q2	us-gaap	Net Income Loss NetIncomeLoss	-57733	USD
CY2013Q2	us-gaap	Net Income Loss NetIncomeLoss	-320492	USD
CY2014Q2	us-gaap	Notes Payable Related Parties Classified Current NotesPayableRelatedPartiesClassifiedCurrent	180738	USD
CY2013Q3	us-gaap	Notes Payable Related Parties Classified Current NotesPayableRelatedPartiesClassifiedCurrent	330738	USD
	us-gaap	Operating Expenses OperatingExpenses	262099	USD
	us-gaap	Operating Expenses OperatingExpenses	1790626	USD
CY2014Q2	us-gaap	Operating Expenses OperatingExpenses	59615	USD
CY2013Q2	us-gaap	Operating Expenses OperatingExpenses	319499	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-178019	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-1664178	USD
CY2014Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-42510	USD
CY2013Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-294932	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-59209	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-124934	USD
CY2014Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-15223	USD
CY2013Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-20114	USD
CY2014Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	8656	USD
CY2013Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	68657	USD
	us-gaap	Proceeds From Issuance Of Preferred Stock And Preference Stock ProceedsFromIssuanceOfPreferredStockAndPreferenceStock	359000	USD
	us-gaap	Proceeds From Issuance Of Preferred Stock And Preference Stock ProceedsFromIssuanceOfPreferredStockAndPreferenceStock	35000	USD
	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt		USD
	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	174325	USD
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	150000	USD
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable		USD
CY2012Q4	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	150000	USD
	us-gaap	Repayments Of Other Debt RepaymentsOfOtherDebt		USD
	us-gaap	Repayments Of Other Debt RepaymentsOfOtherDebt	125000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	6000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	3020	USD
CY2014Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	3000	USD
CY2013Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense		USD
CY2014Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-12038479	USD
CY2013Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-11801251	USD
	us-gaap	Revenues Revenues	158990	USD
	us-gaap	Revenues Revenues	306930	USD
CY2014Q2	us-gaap	Revenues Revenues	38742	USD
CY2013Q2	us-gaap	Revenues Revenues	90537	USD
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	20793	USD
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	17544	USD
CY2014Q2	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	5180	USD
CY2013Q2	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	3797	USD
	us-gaap	Share Based Goods And Nonemployee Services Transaction Stockholders Equity ShareBasedGoodsAndNonemployeeServicesTransactionStockholdersEquity	618251	USD
CY2014Q2	us-gaap	Stockholders Equity StockholdersEquity	-808817	USD
CY2013Q3	us-gaap	Stockholders Equity StockholdersEquity	-940659	USD
CY2012Q4	us-gaap	Stockholders Equity Note Stock Split Conversion Ratio1 StockholdersEquityNoteStockSplitConversionRatio1	3000	pure
	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives		USD
	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	18055	USD
	us-gaap	Use Of Estimates UseOfEstimates	<!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <p style="font-family: Verdana; FONT-FAMILY: Verdana; MARGIN: 0pt; PADDING-LEFT: 63.35pt; text-align: justify"> <strong>USE OF ESTIMATES</strong></p> <p style="FONT-FAMILY: Verdana; MARGIN: 0pt; PADDING-LEFT: 63.35pt; text-align: justify">  </p> <p style="font-family: Arial; FONT-FAMILY: Arial; FONT-SIZE: 11pt; LINE-HEIGHT: 13pt; MARGIN: 0pt; PADDING-LEFT: 63.7pt; text-align: justify"> In preparing the financial statements, management is required to make estimates and assumptions that affect the reported amounts of assets and liabilities as of the date of the balance sheet and operations for the reporting period. Although these estimates are based on management's knowledge of current events and actions it may undertake in the future, they may ultimately differ from actual results.</p> <!--EndFragment--></div> </div>
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	2059837582	shares
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	1138031145	shares
CY2014Q2	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	2123611595	shares
CY2013Q2	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	2057069710	shares

Files In Submission

Name	View Source	Status
0001091818-14-000223-index-headers.html	Edgar Link	pending
0001091818-14-000223-index.html	Edgar Link	pending
0001091818-14-000223.txt	Edgar Link	pending
0001091818-14-000223-xbrl.zip	Edgar Link	pending
clri-20140630.xml	Edgar Link	completed
clri-20140630.xsd	Edgar Link	pending
clri-20140630_cal.xml	Edgar Link	unprocessable
clri-20140630_def.xml	Edgar Link	unprocessable
clri-20140630_lab.xml	Edgar Link	unprocessable
clri-20140630_pre.xml	Edgar Link	unprocessable
clri0812201410q.htm	Edgar Link	pending
ex311.htm	Edgar Link	pending
ex312.htm	Edgar Link	pending
ex321.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xls	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$CLRI
Cleartronic, Inc. Stock $clri

2014 Q3 Form 10-Q Financial Statement

#000109181814000223 Filed on August 14, 2014

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CLRI Cleartronic, Inc. Stock $clri

2014 Q3 Form 10-Q Financial Statement

#000109181814000223 Filed on August 14, 2014

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CLRI
Cleartronic, Inc. Stock $clri